The phenomenon and rationale of marked dependence of drug concentration on blood sampling site. Implications in pharmacokinetics, pharmacodynamics, toxicology and therapeutics (Part II).
about
Physiologically based pharmacokinetic modeling of arterial - antecubital vein concentration differenceA new approach for pharmacokinetic studies of natural products: measurement of isoliquiritigenin levels in mice plasma, urine and feces using modified automated dosing/blood sampling system.Image-derived input function derived from a supervised clustering algorithm: methodology and validation in a clinical protocol using [11C](R)-rolipramImage-derived input function for brain PET studies: many challenges and few opportunities.Are Physiologically Based Pharmacokinetic Models Reporting the Right C(max)? Central Venous Versus Peripheral Sampling Site.Population-based input function and image-derived input function for [¹¹C](R)-rolipram PET imaging: methodology, validation and application to the study of major depressive disorderComparison of Capillary and Venous Drug Concentrations After Administration of a Single Dose of Risperidone, Paliperidone, Quetiapine, Olanzapine, or Aripiprazole.Comparison of Capillary and Venous Plasma Drug Concentrations After Repeated Administration of Risperidone, Paliperidone, Quetiapine, Olanzapine, or Aripiprazole.Hemato-critical issues in quantitative analysis of dried blood spots: challenges and solutions.Understanding the hysteresis loop conundrum in pharmacokinetic/pharmacodynamic relationships.Plasma radiometabolite correction in dynamic PET studies: Insights on the available modeling approaches.Population Pharmacokinetics of Dexmedetomidine After Short Intravenous Infusion in Chinese Children.Development and application of a human PBPK model for bromodichloromethane to investigate the impacts of multi-route exposure.Kinetic analysis of [11C]befloxatone in the human brain, a selective radioligand to image monoamine oxidase A.Transpulmonary pharmacokinetics of an ACE inhibitor (perindoprilat) in man.Impact of the blood sampling site on time-concentration drug profiles following intravenous or buccal drug administration.Bioavailability of morphine, methadone, hydromorphone, and oxymorphone following buccal administration in cats.Calculation of steady-state distribution delay between central and peripheral compartments in two-compartment models with infusion regimen.Necessity and risks of arterial blood sampling in healthy volunteer studies.Plasma levels of bupivacaine and its metabolites after subacromial infusions in concentrations 2.5 or 5.0 mg/ml.Intranasal midazolam: a comparison of two delivery devices in human volunteers.Minimally invasive input function for 2-18F-fluoro-A-85380 brain PET studies.Why dried blood spots are an ideal tool for CYP1A2 phenotyping.Blood microsampling using capillaries for drug-exposure determination in early preclinical studies: a beneficial strategy to reduce blood sample volumes.Accumulation profiles during quasi-uniform multiple dosing regimens.
P2860
Q24803127-210A44B6-9707-4ED1-B045-1F209D6CF391Q34556877-C8C39594-F6D6-4E3F-B01C-AE041883437BQ35106668-5537E82B-7A6F-4468-B911-352B160312D5Q35524029-57BD32B9-E1BB-49FE-B6C1-230E2C4A5FC6Q35967891-351ACB98-EA53-4183-8C7E-3AD06EBFDE5AQ36319736-AFAA83D7-4071-41D2-A279-12C651B7E0E1Q37461978-621AF6DA-F554-4EF1-A12F-745A2714EF70Q37462252-C050A233-DAA3-4FBD-81E1-EA215CEE4E65Q38128343-52A207A5-6FE0-4CCF-9AC2-7705C3F8BD81Q38204833-2D6B3C1A-320F-4E48-BFB3-90AA61EF0289Q38667698-194B2FB4-EFA5-48AD-BB62-A0886AB41976Q39870047-703D7B5E-C79D-47EE-BCE9-6248929CB0B6Q40230063-1882D216-DCE9-4C59-86C7-F091CE25E573Q41763946-85ADC45A-5C56-47E4-B99B-D29AFC82276CQ43204936-86B18D86-6E00-4E39-81F9-997DE86618DBQ43644262-09C5E058-8D98-4E24-8731-0A26DC9C31CBQ43864266-319D873D-1C0E-4B2F-B38D-02342B2BDBAFQ44316226-F55AEA0B-B865-4C59-8E3D-F7B318B66925Q48127644-94893902-0534-4594-9E92-77B38B26B134Q48315334-9DD62226-D910-477C-9EA4-551E93ADF258Q48653634-9FAE0B0E-DC3F-48FD-BBFA-1F034F4224D4Q48720779-896E54A9-E6BC-426A-B53B-F2E680204B2BQ49060953-BF1F4A87-54C1-484E-A1CD-2ED9ED66C8ABQ51756200-4C6EF2E6-5E32-4936-BF48-E709C4B5A599Q52392999-74A2AB76-B81D-49B1-8930-16D96E6AAA6F
P2860
The phenomenon and rationale of marked dependence of drug concentration on blood sampling site. Implications in pharmacokinetics, pharmacodynamics, toxicology and therapeutics (Part II).
description
1989 nî lūn-bûn
@nan
1989年の論文
@ja
1989年論文
@yue
1989年論文
@zh-hant
1989年論文
@zh-hk
1989年論文
@zh-mo
1989年論文
@zh-tw
1989年论文
@wuu
1989年论文
@zh
1989年论文
@zh-cn
name
The phenomenon and rationale o ...... gy and therapeutics (Part II).
@en
type
label
The phenomenon and rationale o ...... gy and therapeutics (Part II).
@en
prefLabel
The phenomenon and rationale o ...... gy and therapeutics (Part II).
@en
P1476
The phenomenon and rationale o ...... gy and therapeutics (Part II).
@en
P2093
P304
P356
10.2165/00003088-198917040-00005
P577
1989-10-01T00:00:00Z
P6179
1008915177